DB
QIPT

Dmitry Balyasny’s Quipt Home Medical QIPT Stock Holding History

Dmitry Balyasny’s Portfolio QIPT Stock Details QIPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,769
Closed -$89.5K – 2690
2023
Q1 		$89.5K Buy
+12,769
New +$78.7K ﹤0.01% 2324

Other funds holding QIPT

CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
NAM
NewGen Asset Management Toronto, Ontario, Canada $243M AUM 86.06% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dmitry Balyasny's QIPT Position: Q2 2023 in Review

Dmitry Balyasny sold out of Quipt Home Medical (QIPT) in Q2 2023, closing a stake of 12,769 shares — an estimated $89.5K sold.

Dmitry Balyasny first reported a position in QIPT in Q1 2023 and held it in 1 quarter. The position peaked at $89.5K in Q1 2023. 92 funds tracked by Wall St. Rank hold QIPT as of Q2 2023.

  • Dmitry Balyasny reported no remaining Quipt Home Medical position as of Q2 2023 after selling out during the quarter.
  • Dmitry Balyasny sold 12,769 Quipt Home Medical shares in Q2 2023, an estimated $89.5K.
  • Dmitry Balyasny first reported a position in Quipt Home Medical in Q1 2023 and held it in 1 quarter.
  • Dmitry Balyasny's Quipt Home Medical position peaked at $89.5K in Q1 2023.
  • 92 funds tracked by Wall St. Rank held Quipt Home Medical as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.